Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Docetaxel
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Docetaxel 140mg/7ml solution for infusion vials
0801050D0AAAHAH
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/16ml solution for infusion vials
0801050D0AAAGAG
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/8ml solution for infusion vials
0801050D0AAAIAI
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.5ml solution for infusion vials and diluent
0801050D0AAAAAA
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.72ml inf vials and diluent
0801050D0AAALAL
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/1ml solution for infusion vials
0801050D0AAACAC
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/2ml solution for infusion vials
0801050D0AAAEAE
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2.88ml inf vials and diluent
0801050D0AAAMAM
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2ml solution for infusion vials and diluent
0801050D0AAABAB
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/4ml solution for infusion vials
0801050D0AAADAD
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/8ml solution for infusion vials
0801050D0AAAFAF
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxceus 140mg/7ml concentrate for inf vials
0801050D0BCACAH
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxceus 20mg/1ml concentrate for solution for infusion vials
0801050D0BCAAAC
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxceus 80mg/4ml concentrate for solution for infusion vials
0801050D0BCABAD
|
Taxceus | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 160mg/8ml concentrate for inf vials
0801050D0BBAEAI
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 20mg/0.5ml solution for infusion vials and diluent
0801050D0BBAAAA
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 20mg/1ml concentrate for inf vials
0801050D0BBACAC
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 80mg/2ml solution for infusion vials and diluent
0801050D0BBABAB
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxotere 80mg/4ml concentrate for inf vials
0801050D0BBADAD
|
Taxotere | Docetaxel | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.